20100713
 Corporate News: Vivus Obesity Drug Works, But FDA Raises Questions   By Jennifer Corbett Dooren, The Wall Street Journal,  Jul 14, 2010  In its safety review of Qnexa, the FDA said it saw increases in heart rate among patients taking the drug but that the clinical significance of the finding is unknown.   
